Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Family history and polygenic risk of cardiovascular disease: independent factors associated with secondary cardiovascular events in patients undergoing carotid endarterectomy

Nathalie Timmerman, Dominique P.V. de Kleijn, Gert J. de Borst, Hester M. den Ruijter, View ORCID ProfileFolkert W. Asselbergs, Gerard Pasterkamp, Saskia Haitjema, View ORCID ProfileSander W. van der Laan
doi: https://doi.org/10.1101/19006718
Nathalie Timmerman
1Department of Vascular Surgery, Division of Surgical Specialties, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominique P.V. de Kleijn
1Department of Vascular Surgery, Division of Surgical Specialties, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gert J. de Borst
1Department of Vascular Surgery, Division of Surgical Specialties, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hester M. den Ruijter
3Laboratory of Experimental Cardiology, Division Heart & Lungs, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Folkert W. Asselbergs
4Department of Cardiology, Division Heart & Lungs, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands
5Durrer Center for Cardiogenetic Research, ICIN-Netherlands Heart Institute, Utrecht, the Netherlands
6Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Folkert W. Asselbergs
Gerard Pasterkamp
2Laboratory of Clinical Chemistry and Hematology, Division Laboratories and Pharmacy, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saskia Haitjema
2Laboratory of Clinical Chemistry and Hematology, Division Laboratories and Pharmacy, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sander W. van der Laan
2Laboratory of Clinical Chemistry and Hematology, Division Laboratories and Pharmacy, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sander W. van der Laan
  • For correspondence: s.w.vanderlaan-2@umcutrecht.nl
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Family history (FHx) of cardiovascular disease (CVD) is a risk factor for CVD and a proxy for cardiovascular heritability. Polygenic risk scores (PRS) summarizing >1 million variants for coronary artery disease (CAD) are associated with incident and recurrent CAD events. However, little is known about the influence of FHx or PRS on secondary cardiovascular events (sCVE) in patients undergoing carotid endarterectomy (CEA).

Methods We included 1,788 CEA patients from the Athero-Express Biobank. A weighted PRS for CAD including 1.7 million variants was calculated (MetaGRS). The composite endpoint of sCVE during three years follow-up included coronary, cerebrovascular and peripheral events and cardiovascular death. We assessed the impact of FHx and MetaGRS on sCVE and carotid plaque composition.

Results Positive FHx was associated with a higher 3-year risk of sCVE independent of cardiovascular risk factors and MetaGRS (adjusted HR 1.40, 95%CI 1.07-1.82, p=0.013). Patients in the highest MetaGRS quintile had a higher 3-year risk of sCVE compared to the rest of the cohort independent of cardiovascular risk factors including FHx (adjusted HR 1.35, 95%CI 1.01-1.79, p=0.043), and their atherosclerotic plaques contained more fat (adjusted OR 1.59, 95%CI, 1.11-2.29, p=0.013) and more macrophages (OR 1.49, 95%CI 1.12-1.99, p=0.006).

Conclusion In CEA patients, both positive FHx and higher MetaGRS were independently associated with increased risk of sCVE. Moreover, higher MetaGRS was associated with vulnerable plaque characteristics. Future studies should unravel underlying mechanisms and focus on the added value of PRS and FHx in individual risk prediction for sCVE.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Dr. van der Laan was funded through grants from the Netherlands CardioVascular Research Initiative of the Netherlands Heart Foundation (CVON 2011/B019 and CVON 2017-20: Generating the best evidence-based pharmaceutical targets for atherosclerosis [GENIUS I&II]). Dr. Timmerman, Dr. De Borst, dr. De Kleijn, and dr. Pasterkamp are funded through the EU 755320 Taxinomisis grant. We acknowledge the European Research Area Network on Cardiovascular diseases (ERA-CVD, grant number 01KL1802). There are no competing interests declared.

Author Declarations

All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.

Not Applicable

I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.

Yes

Footnotes

  • ↵* These authors jointly supervised this project.

  • Declarations of interest: none

  • Financial support, Dr. van der Laan was funded through grants from the Netherlands CardioVascular Research Initiative of the Netherlands Heart Foundation (CVON 2011/B019 and CVON 2017-20: Generating the best evidencebased pharmaceutical targets for atherosclerosis [GENIUS I&II]). Dr. Timmerman, Dr. De Borst, dr. De Kleijn, and dr. Pasterkamp are funded through the EU 755320 Taxinomisis grant. We acknowledge the European Research Area Network on Cardiovascular diseases (ERA-CVD, grant number 01KL1802). There are no competing interests declared.

Data Availability

Data will be available upon request.

  • Abbreviations

    PRS
    polygenic risk score
    CVD
    cardiovascular disease
    CAD
    coronary artery disease
    SNP
    single-nucleotide polymorphism
    FHx
    family history of premature CVD
    MetaGRS
    polygenic risk score for CAD including 1.7 million SNPs associated with CAD CEA carotid endarterectomy
    CVE
    cardiovascular event
    sCVE
    secondary cardiovascular event MI myocardial infarction
    AAA
    abdominal aortic aneurysm
    ACS
    acute coronary syndrome defined as a composite of myocardial infarction and unstable angina pectoris
    PAD
    peripheral artery disease
    GWAS
    large-scale genome wide association studies
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
    Back to top
    PreviousNext
    Posted October 29, 2019.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Family history and polygenic risk of cardiovascular disease: independent factors associated with secondary cardiovascular events in patients undergoing carotid endarterectomy
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Family history and polygenic risk of cardiovascular disease: independent factors associated with secondary cardiovascular events in patients undergoing carotid endarterectomy
    Nathalie Timmerman, Dominique P.V. de Kleijn, Gert J. de Borst, Hester M. den Ruijter, Folkert W. Asselbergs, Gerard Pasterkamp, Saskia Haitjema, Sander W. van der Laan
    medRxiv 19006718; doi: https://doi.org/10.1101/19006718
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Family history and polygenic risk of cardiovascular disease: independent factors associated with secondary cardiovascular events in patients undergoing carotid endarterectomy
    Nathalie Timmerman, Dominique P.V. de Kleijn, Gert J. de Borst, Hester M. den Ruijter, Folkert W. Asselbergs, Gerard Pasterkamp, Saskia Haitjema, Sander W. van der Laan
    medRxiv 19006718; doi: https://doi.org/10.1101/19006718

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Genetic and Genomic Medicine
    Subject Areas
    All Articles
    • Addiction Medicine (76)
    • Allergy and Immunology (199)
    • Anesthesia (54)
    • Cardiovascular Medicine (492)
    • Dentistry and Oral Medicine (90)
    • Dermatology (57)
    • Emergency Medicine (169)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (214)
    • Epidemiology (5719)
    • Forensic Medicine (3)
    • Gastroenterology (217)
    • Genetic and Genomic Medicine (871)
    • Geriatric Medicine (88)
    • Health Economics (232)
    • Health Informatics (767)
    • Health Policy (395)
    • Health Systems and Quality Improvement (254)
    • Hematology (105)
    • HIV/AIDS (185)
    • Infectious Diseases (except HIV/AIDS) (6522)
    • Intensive Care and Critical Care Medicine (393)
    • Medical Education (118)
    • Medical Ethics (28)
    • Nephrology (93)
    • Neurology (851)
    • Nursing (44)
    • Nutrition (142)
    • Obstetrics and Gynecology (164)
    • Occupational and Environmental Health (263)
    • Oncology (516)
    • Ophthalmology (164)
    • Orthopedics (44)
    • Otolaryngology (107)
    • Pain Medicine (48)
    • Palliative Medicine (21)
    • Pathology (149)
    • Pediatrics (252)
    • Pharmacology and Therapeutics (147)
    • Primary Care Research (114)
    • Psychiatry and Clinical Psychology (980)
    • Public and Global Health (2249)
    • Radiology and Imaging (378)
    • Rehabilitation Medicine and Physical Therapy (174)
    • Respiratory Medicine (313)
    • Rheumatology (109)
    • Sexual and Reproductive Health (82)
    • Sports Medicine (82)
    • Surgery (118)
    • Toxicology (25)
    • Transplantation (34)
    • Urology (42)